Ikarian Capital’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-63,191
Closed -$2.01M 105
2023
Q3
$2.01M Buy
63,191
+61,191
+3,060% +$1.94M 0.24% 31
2023
Q2
$165K Buy
+2,000
New +$165K 0.03% 72
2021
Q2
Hold
0
199
2021
Q1
Sell
-4,240
Closed -$2.82M 217
2020
Q4
$2.82M Buy
+4,240
New +$2.82M 0.12% 60